tetracycline and Constipation

tetracycline has been researched along with Constipation* in 5 studies

Trials

1 trial(s) available for tetracycline and Constipation

Article	Year
Use of high efficacy, lower dose triple therapy to reduce side effects of eradicating Helicobacter pylori. The American journal of gastroenterology, 1994, Volume: 89, Issue:1 To evaluate two triple-therapy (TT) regimens of colloidal bismuth subcitrate (CBS), metronidazole, and tetracycline HCl in eradicating Helicobacter pylori, with particular attention to the frequency of resulting adverse effects of the two therapies.. A prospective, randomized controlled trial was conducted in patients with symptoms of dyspepsia who were positive for H. pylori. Subjects received a 14-day course of either 4 x/day therapy of CBS (108 mg), tetracycline HCl (500 mg), and metronidazole (250 mg), or 5 x/day therapy of CBS (108 mg), tetracycline HCl (250 mg), and metronidazole (200 mg). H. pylori status was determined endoscopically by urease test, histology, and culture. Standard questionnaires were administered to determine compliance to treatment and side effects of therapy.. H. pylori was eradicated in 196/213 (92%) patients in the 4 x/day group and 202/210 (96%) in the 5 x/day group (p = 0.07). Side effects were significantly less frequent and less severe in the 5 x/day group (p < 0.01).. We conclude that a lower dose, 5 x/day triple therapy treatment of H. pylori is equally efficacious to the standard 4 x/day therapy, but is accompanied by fewer and milder adverse effects. Topics: Abdominal Pain; Anti-Bacterial Agents; Constipation; Diarrhea; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nausea; Organometallic Compounds; Patient Compliance; Prospective Studies; Tetracycline; Vomiting	1994

Article

Year

Use of high efficacy, lower dose triple therapy to reduce side effects of eradicating Helicobacter pylori.

The American journal of gastroenterology, 1994, Volume: 89, Issue:1

To evaluate two triple-therapy (TT) regimens of colloidal bismuth subcitrate (CBS), metronidazole, and tetracycline HCl in eradicating Helicobacter pylori, with particular attention to the frequency of resulting adverse effects of the two therapies.. A prospective, randomized controlled trial was conducted in patients with symptoms of dyspepsia who were positive for H. pylori. Subjects received a 14-day course of either 4 x/day therapy of CBS (108 mg), tetracycline HCl (500 mg), and metronidazole (250 mg), or 5 x/day therapy of CBS (108 mg), tetracycline HCl (250 mg), and metronidazole (200 mg). H. pylori status was determined endoscopically by urease test, histology, and culture. Standard questionnaires were administered to determine compliance to treatment and side effects of therapy.. H. pylori was eradicated in 196/213 (92%) patients in the 4 x/day group and 202/210 (96%) in the 5 x/day group (p = 0.07). Side effects were significantly less frequent and less severe in the 5 x/day group (p < 0.01).. We conclude that a lower dose, 5 x/day triple therapy treatment of H. pylori is equally efficacious to the standard 4 x/day therapy, but is accompanied by fewer and milder adverse effects.

Topics: Abdominal Pain; Anti-Bacterial Agents; Constipation; Diarrhea; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nausea; Organometallic Compounds; Patient Compliance; Prospective Studies; Tetracycline; Vomiting

1994

Other Studies

4 other study(ies) available for tetracycline and Constipation

Article	Year
[Unusual gastrointestinal and cardiovascular complications in a case of Ehlers-Danlos syndrome]. L'union medicale du Canada, 1972, Volume: 101, Issue:5 Topics: Blind Loop Syndrome; Constipation; Diarrhea; Diverticulum; Duodenal Diseases; Ehlers-Danlos Syndrome; Humans; Ileum; Male; Middle Aged; Mitral Valve Insufficiency; Peptic Ulcer; Streptococcal Infections; Tetracycline	1972
[CASE OF ANTERIOR SPINAL ARTERY SYNDROME]. Naika. Internal medicine, 1964, Volume: 13 Topics: Anterior Spinal Artery Syndrome; Anti-Bacterial Agents; Antibiotics, Antitubercular; Anuria; Arteries; Constipation; Humans; Neurologic Manifestations; Penicillins; Spine; Sulfonamides; Syphilis; Syphilis, Cardiovascular; Tetracycline; Vascular Diseases	1964
[ON A TREATMENT FOR CHRONIC CONSTIPATION]. Semaine therapeutique, 1963, Volume: 39 Topics: Anti-Bacterial Agents; Constipation; Geriatrics; Humans; Spiramycin; Tetracycline	1963
[Treatment of constipation with tetracycline]. Algerie medicale, 1959, Volume: 63 Topics: Anti-Bacterial Agents; Constipation; Humans; Protein Synthesis Inhibitors; Tetracycline	1959